Helius Medical Technologies Inc Class A
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.3% | +0.7% | +34.8% | -72.0% | +198.0% | -67.8% | -12.2% | +1,520.9% | +650.1% | -30.7% | -30.2% | – | |
| – | -51.9% | +36.7% | -4.1% | +58.5% | -17.6% | -21.4% | -20.7% | +7.3% | +74.8% | +0.0% | -57.2% | – | |
| – | – | -72.7% | +433.3% | -312.5% | – | – | – | – | +749.8% | -31.8% | -28.8% | – | |
| – | -10.0% | +21.2% | +10.4% | +23.8% | -14.2% | +2.3% | -13.0% | +4.4% | +3.3% | – | – | – | |
| – | -25.7% | +61.3% | -6.7% | +16.0% | -46.4% | +96.1% | -18.3% | +89.9% | +180.6% | -60.2% | +114.2% | – | |
| – | -26.3% | +49.7% | -2.7% | +18.0% | -20.1% | +25.2% | -17.0% | +68.4% | +153.0% | -62.7% | +114.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -88.2% | -37.5% | -80.0% | +200.0% | +100.0% | +10,366.7% | -99.8% | +126,900.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -130.7% | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -130.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -130.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.